This document is a publication of a European patent application (EP2026029836A1) by the European Patent Office (EPO), detailing "Probiotic compositions having bile acid deconjugation and dehydroxylation properties and methods thereof." The publication date is March 18, 2026. It lists the International Patent Classification (IPC) codes, including A61K 35/742, A61P 31/04, C12N 1/20, C12N 15/52, and A61K 9/00, and specifies designated states within the European Union where patent protection is sought.

As this is a patent application publication, it does not impose direct compliance obligations on regulated entities. However, it is relevant for companies operating in the biotechnology and pharmaceutical sectors, particularly those involved in probiotic development or related intellectual property. Companies should monitor the progress of this patent application through the EPO's official channels if it pertains to their research, development, or commercial interests. No compliance deadlines or penalties are associated with this publication itself.